Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

GB Group Ord Shs GBGPF

GB Group plc is a United Kingdom-based company, which provides identity data intelligence products and services helping organizations recognize and verify all elements of an individual's identity at key interactions in their business processes. The Company's segments include location, identity and fraud. The location segment includes address lookup, verification and capture; e-mail validation; phone verification, and data maintenance services. The identity segment includes document verification, data verification and identity investigation services. Its identity verification solutions can be configured to carry out a wide range of functions, including know your customer checks, anti-money laundering checks, age verification checks and liveness detection. The fraud segment includes transaction fraud monitoring, combating origination fraud and in-life fraud investigation services. It provides artificial intelligence powered screening for automatic onboarding or referral of customers.


OTCPK:GBGPF - Post by User

Post by Duediligence33on Mar 02, 2017 7:44am
124 Views
Post# 25917515

Why I will keep CMED

Why I will keep CMEDLow market cap CEO is knowledgeable and reputable in this business for lengthy time GMP compliant process reputation Oral Disolvable Cannabis wafer in progess Medicinal Cannabis in high regard with medical community Ongoing research projects with doctors High likely takeover target by big pharma Merck or Pfizer due to its prudent medical pharmaceutical stance Open policy for expansion into recreational after legislation passed Increasing patients and revenue bode well for Q12017 financials in March 17 Compared to other cannabis LP grossly undervalued with consensus of $ 14 to 19 Listed on TSX will be part of mutual funds once legalization is passed
<< Previous
Bullboard Posts
Next >>